CD8A and neoplasm: Activation of STING is known to promote the expression of IFN-stimulated genes, including multiple chemokines that recruit CD8+ T cells, which are essential for effective antitumor immunity, as well as MHC class I (MHC-I) genes that are crucial for facilitating tumor cell recognition by CD8+ T cells (8, 9, 11, 12).